LIGNAPHARMA
ActiveLIGNAPHARMA has been active since 2011 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €36k and a net result of €63k. Equity remains stable across the filed fiscal years (±0% per year). Its solvency ranks better than 29% of 11185 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.8% (low).
Checked score
Score 2025
Axes · tick = 2024
Profitability100=
Solvency22▼-1
Growth68=
Stability100
Bankruptcy probability, 12 months
0.8%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €2k at 30 days acceptable
Liquidity tight (current ratio 1.06 against 1.08 in 2024), and 85.5% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 46
Relative position
BE, all sectors
reference
Sector 46
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
14.5%
Return on assets
25.1%
Age of the figures
14 mo
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 17-12-2025, 45 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
45 d early
2024
46 d early
2023
41 d early
2022
41 d early
2021
39 d early
2020
6 d early
2019
14 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
30-06-2026 close14-09-2026 today31-01-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€36k=
2024 · €36k
2019: €36k
2020: €36k
2021: €36k
2022: €36k
2023: €36k
2024: €36k
2019 → 2025
Total assets
€250k▼ 0.2%
2024 · €251k
2019: €195k
2020: €269k
2021: €312k
2022: €235k
2023: €181k
2024: €251k
2019 → 2025
Net result
€63k▼ 14.1%
2024 · €73k
2019: €29k
2020: €72k
2021: €107k
2022: €63k
2023: €82k
2024: €73k
2019 → 2025
Working capital
€12k▼ 25.7%
2024 · €16k
2019: €34k
2020: €9k
2021: €-2k
2022: €26k
2023: €39k
2024: €16k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€36k-€36k=€36k=€36k=€36k=
Operating result€145k-€86k▼ 40.9%€115k▲ 33.6%€110k▼ 4.2%€89k▼ 18.9%
Net result€107k-€63k▼ 40.9%€82k▲ 29.6%€73k▼ 10.5%€63k▼ 14.1%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result has fallen two years in a row; 2025 is 19% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €250k
Fixed assets
€41k▲ 10.5%
Current assets
€209k▼ 2.1%
Equity and liabilities €250k
Equity
€36k=
Provisions
€17k▼ 1.2%
Debt
€197k▼ 0.2%
The debt ratio stays at 78.7%.
Key figures and ratios
EBITDA
€101k▼
2024 · €120k
Cash flow
€74k▼
2024 · €83k
Solvency
14.5%▲
2024 · 14.5%
Current ratio
1.06▼
2024 · 1.08
Quick ratio
0.71▼
2024 · 0.75
Debt / equity
5.42▼
2024 · 5.43
ROE
172.7%▼
2024 · 201.1%
ROA
25.1%▼
2024 · 29.1%
Interest coverage
36.76▼
2024 · 63.31
Debt
€197k▼
2024 · €197k
Debt ≤ 1 year
€197k▼
2024 · €197k
Income taxes
€24k▼
2024 · €36k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€251k€250k▼
Fixed assets21/28€37k€41k▲
Intangible fixed assets21€9k€7k▼
Tangible fixed assets22/27€28k€35k▲
Land and buildings22€24k€25k▲
Plant, machinery and equipment23€1k€869▼
Furniture and vehicles24€2k€9k▲
Other tangible fixed assets26€547€68▼
Current assets29/58€213k€209k▼
Stocks and contracts in progress3€66k€69k▲
Stocks30/36€66k€69k▲
Amounts receivable within one year40/41€42k€9k▼
Trade receivables40€35k€557▼
Other amounts receivable41€8k€8k▲
Current investments50/53€3k€3k=
Cash at bank and in hand54/58€92k€122k▲
Deferred charges and accrued income490/1€10k€6k▼
Equity and liabilities
Total equity and liabilities10/49€251k€250k▼
Equity10/15€36k€36k=
Contributions10/11€33k€33k=
Outside capital11€33k€33k=
Other1109/19€33k€33k=
Reserves13€3k€3k=
Distributable reserves133€3k€3k=
Provisions and deferred taxes16€17k€17k▼
Provisions for liabilities and charges160/5€17k€17k▼
Major repairs and maintenance162€17k€17k▼
Amounts payable17/49€197k€197k▼
Amounts payable within one year42/48€197k€197k▼
Trade debts44€82k€106k▲
Suppliers440/4€82k€106k▲
Advances received on contracts in progress46-€805
Taxes, remuneration and social security45€4k€1k▼
Taxes450/3€4k€1k▼
Other amounts payable47/48€111k€89k▼
Income statement
Code20242025
Remuneration, social security and pensions62€225-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€10k€12k▲
Provisions for liabilities and charges: additions (uses and reversals)635/8€5k€4k▼
Other operating charges640/8€6k€4k▼
Gross operating margin9900€130k€109k▼
Operating profit (loss)9901€110k€89k▼
Financial income75/76B€537€31▼
Recurring financial income75€537€31▼
Financial charges65/66B€2k€3k▲
Recurring financial charges65€2k€3k▲
Profit (loss) for the period before taxes9903€109k€86k▼
Income taxes67/77€36k€24k▼
Profit (loss) for the period9904€73k€63k▼
Profit (loss) for the period to be appropriated9905€73k€63k▼
Appropriation of the result
Profit (loss) to be appropriated9906€73k€63k▼
Profit to be distributed694/7€73k€63k▼
Return on contributions (dividend)694€73k€63k▼
The notes to these accounts (8 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2025
17-12
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2024
16-12
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2023
21-12
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2022
21-12
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2021
23-12
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
30-06
Financial
Highest result since 2019net €107k ▲48.5%
Operating result €145k, net result €107k, both a record.
25-01
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
14-02
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 14 days late
2019
14-01
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
23-02
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 23 days late
2016
21-12
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
4 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Mol · 2 establishment units since 2011
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Gompelbaan 1142400 MolGround area
2,249 m²
Building footprint
562 m²
Volume, LiDAR
3,196 m³
2 parcels, Flanders · tallest building 7.7 m, ±2 floors. Linked by address, not a title deed.
2 establishment units
LIGNAPHARMA
since 20112.203.611.257
Lignapharma
since 20242.358.632.303
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 13025G0628/00C012 | Flanders | 1,574 m² | 1 · 248 m² | 7.7 m · 2 fl. |
| 72020C1408/00N018 | Flanders | 674 m² | 1 · 314 m² | 6.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2022 · 1 entry · 48 EUR awarded · 48 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2022 | 1 | 48 EUR | 48 EUR |
Schemes
Subsidie voor opleiding en advies voor kmo's en zelfstandigen (kmo-portefeuille)
Recognitions · licences · registrations
Food safety, FASFC
1 siteMol2.203.611.257
Similar companies · same sector, comparable size
MV GC
BE 0797.271.704
Ukkel · Eq €36k
LEBBE INTERNATIONAL AGENCIES
BE 0431.864.784
Brugge · Eq €37k
Excellent Food Group
BE 0836.495.633
Wevelgem · Eq €37k
Oude Burg
BE 0466.544.858
Kuurne · Eq €36k
Xenia Services
BE 0674.787.329
Hasselt · Eq €37k
Of 1,631 companies in sector 46170 we hold annual accounts for 660. 446 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-10-2011
Fiscal year end30-06
Activities, NACEBEL
46170Agents in the wholesale of food, beverages and tobacco
46389Wholesale of other food products
10860Manufacture of food products
21201Manufacture of basic pharmaceutical products and pharmaceutical preparations
32300Other manufacturing
46150Agents in the wholesale of furniture, household goods and hardware
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.